Tempest TherapeuticsTPST
13F holders, Q4 2025 (December 31)20holders +4
6new positions
2sold out
$2.87avg. 13F price*
At the end of Q4 2025, 20 institutions reported holding Tempest Therapeutics Inc. (TPST) in their 13F filings, up 4 from Q3 2025. 6 opened new positions and 2 sold out. The largest holders were Sabby Management, LLC ($513K), Vanguard Group Inc. ($467K) and Geode Capital Management, LLC ($127K).
- Company
- Tempest Therapeutics Inc.
- CUSIP
- 87978U207
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $590K |
| Exits | 2 | $55K |
All 13F filers, Q3 2025 → Q4 2025: 215,522 shares bought and 13,802 shares sold, net +201,720 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 20 holders
| Sabby Management, LLC | 4.30% | New | 178,592 | $513K |
| Vanguard Group Inc. | 0.00% | No change | 162,560 | $467K |
| Geode Capital Management, LLC | 0.00% | Add +7.5% | 44,112 | $127K |
| BlackRock, Inc. | 0.00% | No change | 39,068 | $112K |
| FMR LLC | 0.00% | Reduce 0.0% | 33,225 | $95K |
| UBS Group AG | 0.00% | Add +54.0% | 17,542 | $50K |
| Northern Trust Corp. | 0.00% | New | 14,053 | $40K |
| Dimensional Fund Advisors LP | 0.00% | New | 11,444 | $33K |
| DRW Securities, LLC | 0.00% | Reduce -44.5% | 10,447 | $30K |
| Morgan Stanley | 0.00% | Reduce -2.4% | 2,058 | $6K |
| Osaic Holdings, Inc. | 0.00% | Reduce -2.5% | 1,613 | $5K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 1,325 | $4K |
| CIBC Private Wealth Group LLC | 0.00% | Add +134.8% | 1,080 | $3K |
| Federation des caisses Desjardins du Quebec | 0.00% | No change | 292 | $838 |
| Jones Financial Companies LLLP | 0.00% | New | 239 | $686 |
| SBI Securities Co., Ltd. | 0.00% | No change | 56 | $161 |
| Bank of America Corp. | 0.00% | No change | 37 | $107 |
| Parallel Advisors, LLC | 0.00% | No change | 18 | $52 |
| BNP Paribas Financial Markets | 0.00% | No change | 3 | $9 |
| Royal Bank of Canada | 0.00% | New | 8 | $0 |
"% of holder's portfolio" is TPST's weight in each manager's 13F, not the share of Tempest Therapeutics Inc. the manager owns.